aTYR PHARMA INC (ATYR) Form 10-Q Quarterly Reports
aTYR PHARMA INC (ATYR) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ATYR
CIK: 1339970
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerKelly Hayes
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-16 | 8-K | 0001339970-26-000068 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0001623632-26-001548 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-10-01 | 4 | 0002156611-26-000010 | View SEC Doc Filr Page |
| 3 | 2026-10-01 | 2026-10-01 | 3 | 0002156611-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-09-24 | 2026-09-24 | 8-K | 0001339970-26-000065 | View SEC Doc Filr Page |
| DEF 14A | 2026-09-11 | 2026-10-16 | DEF 14A | 0001339970-26-000061 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-31 | 2026-10-16 | PRE 14A | 0001339970-26-000058 | View SEC Doc Filr Page |
| S-8 | 2026-08-07 | — | S-8 | 0001339970-26-000055 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001339970-26-000053 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-07 | 8-K | 0001339970-26-000051 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-001937 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-30 | 8-K | 0001339970-26-000042 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002254 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0001623632-26-000980 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-03 | 8-K | 0001339970-26-000039 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-06-05 | — | SCHEDULE 13G/A Filing | 0000315066-26-001409 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-06-01 | 8-K | 0001339970-26-000036 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-27 | 4 | 0001236447-26-000006 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001339970-26-000033 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001339970-26-000030 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-11 | 4 | 0001376043-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-11 | 4 | 0001643653-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-11 | 4 | 0001684258-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-11 | 4 | 0001781292-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-05-11 | 4 | 0001602225-26-000003 | View SEC Doc Filr Page |